{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:38Z","timestamp":1783528598904,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["24ZDYF0229"],"award-info":[{"award-number":["24ZDYF0229"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04641-7","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:56:00Z","timestamp":1759564560000},"page":"3665-3671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the causal effects of hypertension, candesartan, lisinopril, and ramipril on gout"],"prefix":"10.1007","volume":"399","author":[{"given":"Yuchi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangkaobei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"9","key":"4641_CR1","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/hypertensionaha.122.17956","volume":"79","author":"C Borghi","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A (2022) Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension 79(9):1927\u20131936. https:\/\/doi.org\/10.1161\/hypertensionaha.122.17956","journal-title":"Hypertension"},{"issue":"2","key":"4641_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11906-003-0074-1","volume":"5","author":"KD Burns","year":"2003","unstructured":"Burns KD, Li N (2003) The role of angiotensin II-stimulated renal tubular transport in hypertension. Curr Hypertens Rep 5(2):165\u2013171. https:\/\/doi.org\/10.1007\/s11906-003-0074-1","journal-title":"Curr Hypertens Rep"},{"key":"4641_CR3","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.12659\/msm.899852","volume":"22","author":"C Chen","year":"2016","unstructured":"Chen C, L\u00fc JM, Yao Q (2016) Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview. Med Sci Monit 22:2501\u20132512. https:\/\/doi.org\/10.12659\/msm.899852","journal-title":"Med Sci Monit"},{"key":"4641_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LA (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344:d8190. https:\/\/doi.org\/10.1136\/bmj.d8190","journal-title":"BMJ"},{"issue":"10287","key":"4641_CR5","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/s0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout Lancet 397(10287):1843\u20131855. https:\/\/doi.org\/10.1016\/s0140-6736(21)00569-9","journal-title":"Gout Lancet"},{"issue":"11","key":"4641_CR6","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.numecd.2022.08.017","volume":"32","author":"N Ding","year":"2022","unstructured":"Ding N, He L, Li C, Su Y (2022) Uric acid and blood pressure in NHANES dated from 2009 to 2018: a cross-sectional research. Nutr Metab Cardiovasc Dis 32(11):2568\u20132578. https:\/\/doi.org\/10.1016\/j.numecd.2022.08.017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4641_CR7","doi-asserted-by":"publisher","first-page":"1096296","DOI":"10.3389\/fphys.2022.1096296","volume":"13","author":"LA Ertuglu","year":"2022","unstructured":"Ertuglu LA, Mutchler AP, Yu J, Kirabo A (2022) Inflammation and oxidative stress in salt sensitive hypertension; the role of the NLRP3 inflammasome. Front Physiol 13:1096296. https:\/\/doi.org\/10.3389\/fphys.2022.1096296","journal-title":"Front Physiol"},{"key":"4641_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106333","author":"W Hao","year":"2023","unstructured":"Hao W, Feng C (2023) Research progress on pyroptosis and its effect on the central nervous system. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2023.106333","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4641_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/hypertensionaha.121.17263","volume":"78","author":"D Hirohama","year":"2021","unstructured":"Hirohama D, Nishimoto M, Ayuzawa N, Kawarazaki W, Fujii W, Oba S, Shibata S, Marumo T, Fujita T (2021) Activation of Rac1-mineralocorticoid receptor pathway contributes to renal injury in salt-loaded db\/db mice. Hypertension 78(1):82\u201393. https:\/\/doi.org\/10.1161\/hypertensionaha.121.17263","journal-title":"Hypertension"},{"key":"4641_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20133328","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4641_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.mayocp.2022.02.027","volume":"97","author":"N Leung","year":"2022","unstructured":"Leung N, Yip K, Pillinger MH, Toprover M (2022) Lowering and raising serum urate levels: off-label effects of commonly used medications. Mayo Clin Proc 97(7):1345\u20131362. https:\/\/doi.org\/10.1016\/j.mayocp.2022.02.027","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4641_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/atm-20-3458","volume":"9","author":"J Liu","year":"2021","unstructured":"Liu J, Chen L, Yuan H, Huang K, Li G, Sun N, Huo Y (2021a) Survey on uric acid in Chinese subjects with essential hypertension (SUCCESS): a nationwide cross-sectional study. Ann Transl Med 9(1):27. https:\/\/doi.org\/10.21037\/atm-20-3458","journal-title":"Ann Transl Med"},{"key":"4641_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W (2021b) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021:1470380. https:\/\/doi.org\/10.1155\/2021\/1470380","journal-title":"Oxid Med Cell Longev"},{"key":"4641_CR14","doi-asserted-by":"publisher","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","volume":"14","author":"YR Liu","year":"2023","unstructured":"Liu YR, Wang JQ, Li J (2023) Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol 14:1137822. https:\/\/doi.org\/10.3389\/fimmu.2023.1137822","journal-title":"Front Immunol"},{"issue":"7081","key":"4641_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"issue":"6","key":"4641_CR16","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/hypertensionaha.123.21369","volume":"81","author":"M Nishimoto","year":"2024","unstructured":"Nishimoto M, Griffin KA, Wynne BM, Fujita T (2024) Salt-sensitive hypertension and the kidney. Hypertension 81(6):1206\u20131217. https:\/\/doi.org\/10.1161\/hypertensionaha.123.21369","journal-title":"Hypertension"},{"issue":"5","key":"4641_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/hypertensionaha.122.20824","volume":"80","author":"CH Park","year":"2023","unstructured":"Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Lee J, Sung S, Jung JY, Hyun YY, Oh KH, Kang SW, Han SH (2023) Intrarenal renin-angiotensin system activation alters relationship between systolic blood pressure and progression of chronic kidney disease. Hypertension 80(5):1024\u20131034. https:\/\/doi.org\/10.1161\/hypertensionaha.122.20824","journal-title":"Hypertension"},{"issue":"5\u20136","key":"4641_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/b:card.0000015855.02485.e3","volume":"17","author":"AJ Reyes","year":"2003","unstructured":"Reyes AJ (2003) Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 17(5\u20136):397\u2013414. https:\/\/doi.org\/10.1023\/b:card.0000015855.02485.e3","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"4641_CR19","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/s0002-9440(10)64130-2","volume":"158","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega M, Lorenzo O, Rup\u00e9rez M, Blanco J, Egido J (2001) Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 158(5):1743\u20131756. https:\/\/doi.org\/10.1016\/s0002-9440(10)64130-2","journal-title":"Am J Pathol"},{"key":"4641_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep20148","volume":"6","author":"M Sakiyama","year":"2016","unstructured":"Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakamura T, Nakayama A, Higashino T, Naito M, Suma S, Hishida A, Satoh T, Sakurai Y, Takada T, Ichida K, Ooyama H, Shimizu T, Shinomiya N (2016) The effects of URAT1\/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout\/hyperuricemia progression. Sci Rep 6:20148. https:\/\/doi.org\/10.1038\/srep20148","journal-title":"Sci Rep"},{"issue":"2","key":"4641_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00125-023-06031-1","volume":"67","author":"G Savarese","year":"2024","unstructured":"Savarese G, Lindberg F, Filippatos G, Butler J, Anker SD (2024) Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists. Diabetologia 67(2):246\u2013262. https:\/\/doi.org\/10.1007\/s00125-023-06031-1","journal-title":"Diabetologia"},{"key":"4641_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.835154","volume":"13","author":"H Sun","year":"2022","unstructured":"Sun H, Chang X, Bian N, An Y, Liu J, Leng S, Wang G (2022) Adipose tissue insulin resistance is positively associated with serum uric acid levels and hyperuricemia in Northern Chinese adults. Front Endocrinol (Lausanne) 13:835154. https:\/\/doi.org\/10.3389\/fendo.2022.835154","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4641_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","volume":"45","author":"J Sundstr\u00f6m","year":"2005","unstructured":"Sundstr\u00f6m J, Sullivan L, D\u2019Agostino RB, Levy D, Kannel WB, Vasan RS (2005) Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45(1):28\u201333. https:\/\/doi.org\/10.1161\/01.HYP.0000150784.92944.9a","journal-title":"Hypertension"},{"issue":"1","key":"4641_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12933-023-02038-5","volume":"22","author":"L Tan","year":"2023","unstructured":"Tan L, Liu Y, Liu J, Zhang G, Liu Z, Shi R (2023) Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study. Cardiovasc Diabetol 22(1):311. https:\/\/doi.org\/10.1186\/s12933-023-02038-5","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"4641_CR25","doi-asserted-by":"publisher","first-page":"F826","DOI":"10.1152\/ajprenal.00012.2017","volume":"313","author":"D Toyoki","year":"2017","unstructured":"Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, Uchida S (2017) Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol Renal Physiol 313(3):F826-f834. https:\/\/doi.org\/10.1152\/ajprenal.00012.2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"4641_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1055\/s-0042-113183","volume":"66","author":"S Ueno","year":"2016","unstructured":"Ueno S, Hamada T, Taniguchi S, Ohtani N, Miyazaki S, Mizuta E, Ohtahara A, Ogino K, Yoshida A, Kuwabara M, Yoshida K, Ninomiya H, Kotake H, Taufiq F, Yamamoto K, Hisatome I (2016) Effect of antihypertensive drugs on uric acid metabolism in patients with hypertension: cross-sectional cohort study. Drug Res (Stuttg) 66(12):628\u2013632. https:\/\/doi.org\/10.1055\/s-0042-113183","journal-title":"Drug Res (Stuttg)"},{"issue":"6","key":"4641_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/hypertensionaha.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75(6):1334\u20131357. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15026","journal-title":"Hypertension"},{"key":"4641_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-3-7","volume":"3","author":"IM van der Meer","year":"2010","unstructured":"van der Meer IM, Cravedi P, Remuzzi G (2010) The role of renin angiotensin system inhibition in kidney repair. Fibrogenesis Tissue Repair 3:7. https:\/\/doi.org\/10.1186\/1755-1536-3-7","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"6","key":"4641_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11906-024-01295-3","volume":"26","author":"R Vareldzis","year":"2024","unstructured":"Vareldzis R, Perez A, Reisin E (2024) Hyperuricemia: an intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension. Curr Hypertens Rep 26(6):237\u2013245. https:\/\/doi.org\/10.1007\/s11906-024-01295-3","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"4641_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H (2016) Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis 67(5):728\u2013741. https:\/\/doi.org\/10.1053\/j.ajkd.2015.10.011","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4641_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/hypertensionaha.123.20577","volume":"80","author":"H Yamaguchi","year":"2023","unstructured":"Yamaguchi H, Gomez RA, Sequeira-Lopez MLS (2023) Renin cells, from vascular development to blood pressure sensing. Hypertension 80(8):1580\u20131589. https:\/\/doi.org\/10.1161\/hypertensionaha.123.20577","journal-title":"Hypertension"},{"key":"4641_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1874312901812010094","volume":"12","author":"W Zhu","year":"2018","unstructured":"Zhu W, Deng Y, Zhou X (2018) Multiple membrane transporters and some immune regulatory genes are major genetic factors to gout. Open Rheumatol J 12:94\u2013113. https:\/\/doi.org\/10.2174\/1874312901812010094","journal-title":"Open Rheumatol J"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04641-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:59:57Z","timestamp":1772006397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04641-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4641"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04641-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}